We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.

U.S. Army Garrison Humphreys Soldiers conducted 48-hour field operations as part of the Freedom Shield 25, here, March ...

United Therapeutics Co. has a fifty-two week low of $221.53 and a fifty-two week high of $417.82. The company has a market cap of $13.80 billion, a PE ratio of 13.49, a price-to-earnings-growth ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD. For more information about ...

On a 300-acre farm in an undisclosed location in rural Wisconsin, surrounded by fields dotted with big red barns and bordered ...

Sun Pharmaceutical Industries Ltd and Nasdaq-listed Checkpoint Therapeutics ... and provide accelerated access to UNLOXCYT in the United States, Europe and other markets worldwide,” he said.

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...